Darbo motyvacija ir savarankiškumas karjeroje kaip moterų subjektyvios sėkmės STEM karjeroje prediktoriai

The minority status of women in science, technology, engineering and mathematics (STEM) professions makes their successful career development difficult. Due to gender-specific challenges, career dissatisfaction contributes to women dropping out of STEM careers. Therefore, women’s subjective career success (SCS) is important to persist and progress in their STEM careers. This study analyzed the influence of different types of work motivation and the perceived career autonomy on SCS of women. Specifically, 318 women working in STEM professions in Germany completed a quantitative online questionnaire. Using an ordinary least squares regression for variables predicting SCS measured as career satisfaction, we found that an intrinsic work motivation positively affects women’s SCS. The perception of high career autonomy was related positively, and the perception of low career autonomy was related negatively to SCS. Unexpectedly, the findings also revealed the positive influence of income on women’s SCS. The findings show that intrinsic work motivation and high perceived autonomy are promoting factors for SCSs, which could also contribute to their retention in STEM professions.Mokslo, technologijų, inžinerijos ir matematikos (STEM) profesijose moterų yra mažuma, todėl moterims čia sunku siekti sėkmingos karjeros. Moterų nepasitenkinimas savo profesija kyla dėl su socialine lytimi susijusių problemų ir prisideda prie to, kad moterys nutraukia STEM veiklas. Todėl norinčioms išlikti ir tobulėti STEM profesijose moterims svarbi subjektyvi karjeros sėkmė (SKS). Šiame tyrime analizuojama įvairių darbo motyvacijos tipų ir savarankiškumo karjeroje įtaka moterų subjektyviai karjeros sėkmei. 318 STEM profesijose Vokiet­ijoje dirbančių moterų užpildė kiekybinį klausimyną internete. Naudodami įprastą mažiausiųjų kvadratų regresiją subjektyvią karjeros sėkmę (matuojamą pasitenkinimu karjera) prognozuojantiems kintamiesiems nustatėme, kad teigiamai moterų SKS prognozuoja vidinė darbo motyvacija. Didelis savarankiškumas karjeroje su SKS susijęs teigiamai, o mažas savarankiškumas karjeroje – neigiamai. Tyrimo rezultatai netikėtai atskleidė ir teigiamą pajamų įtaką moterų SKS. Rezultatai rodo, kad vidinė darbo motyvacija ir didelis savarankiškumas yra tie skatinantys SKS veiksniai, kurie taip pat galėtų prisidėti prie moterų išlaikymo STEM profesijose

Operational Experience with Autonomous Star Trackers on ESA Interplanetary Spacecraft

Mars Express (MEX), Rosetta and Venus Express (VEX) are ESA interplanetary spacecrafts (S/C) launched in June 2003, March 2004 and November 2005, respectively. Mars Express was injected into Mars orbit end of 2003 with routine operations starting in spring 2004. Rosetta is since launch on its way to rendezvous comet Churyumov-Gerasimenko in 2014. It has completed several test and commissioning activities and is performing several planetary swingbys (Earth in spring 2005, Mars in spring 2007, Earth in autumn 2007 and again two years later). Venus Express has also started routine operations since the completion of the Venus orbit insertion maneuver sequence beginning of May 2006. All three S/C are three axes stabilized with a similar attitude and orbit control system (AOCS). The attitude is estimated on board using star and rate sensors and controlled using four reaction wheels. A bipropellant reaction control system with 10N thrusters serves for wheel off loadings and attitude control in safe mode. Mars Express and Venus Express have an additional 400N engine for the planetary orbit insertion. Nominal Earth communication is accomplished through a high gain antenna. All three S/C are equipped with a redundant set of autonomous star trackers (STR) which are based on almost the same hardware. The STR software is especially adapted for the respective mission. This paper addresses several topics related to the experience gained with the STR operations on board the three S/C so far

Visual Impairment and Low Vision Aids : A Comparison between Children and Adults

(1) Background: This study aims to highlight differences in the etiology and fitting of low vision aids in visually impaired children and adolescents in comparison to adults. (2) Methods: A retrospective data collection from visually impaired patients presenting to obtain assistive devices from 1 January 2016 to 30 April 2020 was conducted. A total of 502 patients were included. Inclusion criteria were a minimum age of 4 years and the chart notation of a best-corrected distance visual acuity in the patient record prior to the fitting of magnifying visual aids. (3) Results: Of the 502 patients, 147 (29.3%) were children under the age of 18 years. The most common cause of visual impairment in children was albinism, and in adults, it was age-related macular degeneration (AMD). Children showed better distance visual acuity, with a median of 0.88 logMAR (Logarithm of the Minimum Angle of Resolution) compared to 1.0 in adults (p = 0.001). Near visual acuity was also significantly better, with a median of 0.54 logMAR in children compared to 0.9 in adults (p < 0.001). Near and distance visual acuity were significantly improved by fitting magnifying visual aids (p < 0.001). After fitting, near visual acuity averaged 0.3 logMAR, and distance visual acuity, 0.7. The most commonly prescribed aids were optical vision aids, which 68.5% of the patients received; 43.8% received electronic aids. In children, optical aids were more frequently prescribed, and in adults, electronic and acoustic aids (p < 0.001). (4) Conclusion: Visually impaired patients can regain the ability to read and improve distance vision by using individually adapted and tested magnifying vision aids, often with optical aids alone. Differences between children and adults could be discovered in the etiology and severity of visual impairment, as well as in the provision type of low vision aids

Gemfibrozil-Induced Intracellular Triglyceride Increase in SH-SY5Y, HEK and Calu-3 Cells

Gemfibrozil is a drug that has been used for over 40 years to lower triglycerides in blood. As a ligand for peroxisome proliferative-activated receptor-alpha (PPARα), which is expressed in many tissues, it induces the transcription of numerous genes for carbohydrate and lipid-metabolism. However, nothing is known about how intracellular lipid-homeostasis and, in particular, triglycerides are affected. As triglycerides are stored in lipid-droplets, which are known to be associated with many diseases, such as Alzheimer’s disease, cancer, fatty liver disease and type-2 diabetes, treatment with gemfibrozil could adversely affect these diseases. To address the question whether gemfibrozil also affects intracellular lipid-levels, SH-SY5Y, HEK and Calu-3 cells, representing three different metabolically active organs (brain, lung and kidney), were incubated with gemfibrozil and subsequently analyzed semi-quantitatively by mass-spectrometry. Importantly, all cells showed a strong increase in intracellular triglycerides (SH-SY5Y: 170.3%; HEK: 272.1%; Calu-3: 448.1%), suggesting that the decreased triglyceride-levels might be due to an enhanced cellular uptake. Besides the common intracellular triglyceride increase, a cell-line specific alteration in acylcarnitines are found, suggesting that especially in neuronal cell lines gemfibrozil increases the transport of fatty acids to mitochondria and therefore increases the turnover of fatty acids for the benefit of additional energy supply, which could be important in diseases, such as Alzheimer’s disease

Vitamin D and Its Analogues: From Differences in Molecular Mechanisms to Potential Benefits of Adapted Use in the Treatment of Alzheimer’s Disease

Lifestyle habits and insufficient sunlight exposure lead to a high prevalence of vitamin D hypovitaminosis, especially in the elderly. Recent studies suggest that in central Europe more than 50% of people over 60 years are not sufficiently supplied with vitamin D. Since vitamin D hypovitaminosis is associated with many diseases, such as Alzheimer’s disease (AD), vitamin D supplementation seems to be particularly useful for this vulnerable age population. Importantly, in addition to vitamin D, several analogues are known and used for different medical purposes. These vitamin D analogues differ not only in their pharmacokinetics and binding affinity to the vitamin D receptor, but also in their potential side effects. Here, we discuss these aspects, especially those of the commonly used vitamin D analogues alfacalcidol, paricalcitol, doxercalciferol, tacalcitol, calcipotriol, and eldecalcitol. In addition to their pleiotropic effects on mechanisms relevant to AD, potential effects of vitamin D analogues on comorbidities common in the context of geriatric diseases are summarized. AD is defined as a complex neurodegenerative disease of the central nervous system and is commonly represented in the elderly population. It is usually caused by extracellular accumulation of amyloidogenic plaques, consisting of amyloid (Aβ) peptides. Furthermore, the formation of intracellular neurofibrillary tangles involving hyperphosphorylated tau proteins contributes to the pathology of AD. In conclusion, this review emphasizes the importance of an adequate vitamin D supply and discusses the specifics of administering various vitamin D analogues compared with vitamin D in geriatric patients, especially those suffering from AD

Interprofessional education: a necessity in Alzheimer’s dementia care—a pilot study

Introduction: Interprofessional collaboration is seen as an indispensable prerequisite for high-quality health services and patient care, especially for complex diseases such as dementia. Thus, the current project aimed to extend interprofessional and competency-based education in the field of dementia care to the previously understudied therapy professions of nutrition, speech-language pathology, and physiotherapy. Methods: A three-day workshop was designed to provide specific learning objectives related to patient-centered dementia care, as well as competences for interprofessional collaboration. Teaching and learning approaches included case-based learning in simulated interprofessional case-conferences and peerteaching. A total of 42 students (n  =  20 nutrition therapy and counseling, n  =  8 speech-language pathology, n  =  14 physiotherapy), ranging from first to seventh semester, finished the whole workshop and were considered in data analysis. Changes in self-perceived attitudes toward interprofessional collaboration and education were measured by the German version of the UWE-IP. An in-house questionnaire was developed to evaluate knowledge and skills in the field of dementia, dementia management and interprofessional collaboration. Results: Participation in the workshop led to significant improvements in the total scores of the UWE-IP-D and the in-house questionnaire, as well as their respective subscales. Moderate to large effect sizes were achieved. All professions improved significantly in both questionnaires with large effect sizes. Significant differences between professions were found in the UWE-IP-D total score between students of speech-language pathology and physiotherapy in the posttest. Students of nutrition therapy and counseling revealed a significant lower level of self-perceived knowledge and skills in the in-house questionnaire pre- and post-testing. Discussion: The pilot-study confirms the effectiveness of interprofessional education to promote generic and interprofessional dementia care competencies and to develop positive attitudes toward interprofessional learning and collaboration in the therapy professions, thus increasing professional diversity in interprofessional education research. Differences between professions were confounded by heterogenous semester numbers and participation conditions. To achieve a curricular implementation, interprofessional education should be expanded to include a larger group of participants belonging to different professions, start early in the study program, and be evaluated over the long term

Effect of Caffeine and Other Methylxanthines on Aβ-Homeostasis in SH-SY5Y Cells

Methylxanthines (MTX) are alkaloids derived from the purine-base xanthine. Whereas especially caffeine, the most prominent known MTX, has been formerly assessed to be detrimental, this point of view has changed substantially. MTXs are discussed to have beneficial properties in neurodegenerative diseases, however, the mechanisms of action are not completely understood. Here we investigate the effect of the naturally occurring caffeine, theobromine and theophylline and the synthetic propentofylline and pentoxifylline on processes involved in Alzheimer’s disease (AD). All MTXs decreased amyloid-β (Aβ) level by shifting the amyloid precursor protein (APP) processing from the Aβ-producing amyloidogenic to the non-amyloidogenic pathway. The α-secretase activity was elevated whereas β-secretase activity was decreased. Breaking down the molecular mechanism, caffeine increased protein stability of the major α-secretase ADAM10, downregulated BACE1 expression and directly decreased β-secretase activity. Additionally, APP expression was reduced. In line with literature, MTXs reduced oxidative stress, decreased cholesterol and a decreased in Aβ1-42 aggregation. In conclusion, all MTXs act via the pleiotropic mechanism resulting in decreased Aβ and show beneficial properties with respect to AD in neuroblastoma cells. However, the observed effect strength was moderate, suggesting that MTXs should be integrated in a healthy diet rather than be used exclusively to treat or prevent AD

Switching between intravenous and subcutaneous trastuzumab: safety results from the PrefHer trial

Aim: To assess the safety and tolerability of switching between subcutaneous (SC) and intravenous (IV) trastuzumab in the PrefHer study (NCT01401166). Patients and methods: Patients with HER2-positive early breast cancer completed (neo)adjuvant chemotherapy and were randomised to receive four cycles of SC trastuzumab, via single-use injection device (SID; Cohort 1) or hand-held syringe (Cohort 2), followed by four cycles of IV, or vice versa (the crossover period presented here) as part of their 18 standard cycles of adjuvant trastuzumab treatment. Adverse events (AEs) were reported using standard criteria. Results: Overall, fewer AEs were reported during the IV treatment periods, regardless of administration sequence (IV→SC or SC→IV). Differences in AEs between the SC and IV periods were partly due to variances in grade 1 and 2 local injection site reactions (ISRs) and systemic administration-related reactions (ARRs) and these occurred mainly during SC treatment, as expected. When ISRs and ARRs were excluded, rates of AEs were higher during the first treatment period, compared with the second, in both treatment sequences; otherwise there was no clear pattern in the type of AEs reported. Rates of clinically important events, including grade ≥3 AEs, serious AEs, AEs leading to study drug discontinuation and cardiac AEs, were low and similar between treatment arms (<5%). There were no grade 4 or 5 AEs. No new safety signals for trastuzumab were observed. Conclusions: PrefHer revealed that switching from IV to SC trastuzumab (hand-held syringe or SID) or vice versa did not impact the known safety profile of trastuzumab